A Phase I Clinical Trial of Trametinib in Combination With TAS-102 in Patients With Chemotherapy-Resistant RAS-Mutated (PIK3CA/PTEN-Wild-Type) Metastatic Colorectal Cancer
Phase of Trial: Phase I
Latest Information Update: 10 May 2018
At a glance
- Drugs Tipiracil/trifluridine (Primary) ; Trametinib (Primary)
- Indications Colorectal cancer
- Focus Adverse reactions
- 22 Mar 2018 Status changed from not yet recruiting to recruiting.
- 15 Jan 2018 Planned End Date changed from 1 Jun 2019 to 1 Dec 2019.
- 15 Jan 2018 Planned primary completion date changed from 1 Jun 2019 to 1 Dec 2019.